158 related articles for article (PubMed ID: 36123910)
1. Distinguishing pancreatic solid serous cystadenomas from nonfunctional pancreatic neuroendocrine tumors by computed tomography: A propensity score analysis.
Fang X; Jiang H; Cao K; Li J; Liu F; Wang L; Lu J; Shao C; Bian Y
Medicine (Baltimore); 2022 Sep; 101(37):e30523. PubMed ID: 36123910
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
[TBL] [Abstract][Full Text] [Related]
3. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
[TBL] [Abstract][Full Text] [Related]
5. A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis.
Kim C; Byun JH; Hong SM; An S; Kim JH; Lee SS; Kim HJ
Abdom Radiol (NY); 2017 Dec; 42(12):2835-2842. PubMed ID: 28624923
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
[TBL] [Abstract][Full Text] [Related]
7. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
[TBL] [Abstract][Full Text] [Related]
8. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
[TBL] [Abstract][Full Text] [Related]
9. A nomogram to preoperatively predict the aggressiveness of non-functional pancreatic neuroendocrine tumors based on CT features.
Shen X; Yang F; Jiang T; Zheng Z; Chen Y; Tan C; Ke N; Qiu J; Liu X; Zhang H; Wang X
Eur J Radiol; 2024 Feb; 171():111284. PubMed ID: 38232572
[TBL] [Abstract][Full Text] [Related]
10. Serous cystadenoma of head pancreas masquerading as pancreatic neuroendocrine tumor: Treated by Whipple's pancreaticoduodenectomy.
Kumarasamy S; Kumar M; Sakaray Y; Savlania A; Tandup C; Kaman L
J Cancer Res Ther; 2023; 19(3):829-831. PubMed ID: 37470621
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.
Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z
Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of pancreatic serous cystadenoma from endocrine tumor and intraductal papillary mucinous neoplasm based on washout pattern on multiphase CT.
Sahara S; Kawai N; Sato M; Ikoma A; Minamiguchi H; Nakai M; Sanda H; Nakata K; Takeuchi T; Tanaka T; Shirai S; Sonomura T
J Comput Assist Tomogr; 2012; 36(2):231-6. PubMed ID: 22446365
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of Solid Pseudopapillary Tumor and Non-Functional Neuroendocrine Tumors of the Pancreas Based on CT Delayed Imaging: A Propensity Score Analysis.
Liu F; Li J; Fang X; Meng Y; Zhang H; Yu J; Feng X; Wang L; Jiang H; Lu J; Bian Y; Shao C
Acad Radiol; 2022 Mar; 29(3):350-357. PubMed ID: 33731286
[TBL] [Abstract][Full Text] [Related]
14. CT-based differentiation of solid pseudopapillary neoplasm and nonfunctional neuroendocrine tumor of pancreas.
Ma Y; Wen Y; Zhong J
Diagn Interv Radiol; 2022 Mar; 28(2):124-130. PubMed ID: 35548896
[TBL] [Abstract][Full Text] [Related]
15. Accurate non-invasive grading of nonfunctional pancreatic neuroendocrine tumors with a CT derived radiomics signature.
Javed AA; Zhu Z; Kinny-Köster B; Habib JR; Kawamoto S; Hruban RH; Fishman EK; Wolfgang CL; He J; Chu LC
Diagn Interv Imaging; 2024 Jan; 105(1):33-39. PubMed ID: 37598013
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis between pancreatic solid pseudopapillary tumors and pancreatic neuroendocrine tumors based on contrast enhanced ultrasound imaging features.
Zhang Q; Qiu YJ; Yang DH; Lu XY; Chen S; Dong Y; Wang WP
Clin Hemorheol Microcirc; 2023; 85(4):421-431. PubMed ID: 37718786
[TBL] [Abstract][Full Text] [Related]
18. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of texture analysis for grading pancreatic neuroendocrine tumors on contrast-enhanced computed tomography and apparent diffusion coefficient maps.
Ohki K; Igarashi T; Ashida H; Takenaga S; Shiraishi M; Nozawa Y; Ojiri H
Jpn J Radiol; 2021 Jan; 39(1):66-75. PubMed ID: 32885378
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced ultrasound (CEUS) and shear wave elastography (SWE) features for characterizing serous microcystic adenomas (SMAs): In comparison to pancreatic neuroendocrine tumors (pNETs).
Tian XF; Yu LY; Yang DH; Zuo D; Cao JY; Wang Y; Yang ZY; Lou WH; Wang WP; Gong W; Dong Y
Heliyon; 2024 Feb; 10(3):e25185. PubMed ID: 38327470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
